Corbus Pharmaceuticals Holdings, Inc. Quarterly Current Ratio in % from Q2 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly Current Ratio history and growth rate from Q2 2015 to Q2 2024.
  • Corbus Pharmaceuticals Holdings, Inc. Current Ratio for the quarter ending June 30, 2024 was 287 %, a 17.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 287 -61.3 -17.6% Jun 30, 2024
Q1 2024 203 -211 -50.9% Mar 31, 2024
Q4 2023 147 -331 -69.2% Dec 31, 2023
Q3 2023 234 -274 -53.9% Sep 30, 2023
Q2 2023 348 -231 -39.9% Jun 30, 2023
Q1 2023 414 -192 -31.7% Mar 31, 2023
Q4 2022 479 -115 -19.3% Dec 31, 2022
Q3 2022 508 +20.3 +4.16% Sep 30, 2022
Q2 2022 579 +216 +59.6% Jun 30, 2022
Q1 2022 606 +321 +113% Mar 31, 2022
Q4 2021 593 +380 +178% Dec 31, 2021
Q3 2021 488 +314 +180% Sep 30, 2021
Q2 2021 363 +195 +116% Jun 30, 2021
Q1 2021 285 +110 +63.4% Mar 31, 2021
Q4 2020 213 +33.7 +18.8% Dec 31, 2020
Q3 2020 174 -33.6 -16.2% Sep 30, 2020
Q2 2020 168 -64.9 -27.9% Jun 30, 2020
Q1 2020 174 -87.5 -33.4% Mar 31, 2020
Q4 2019 180 -237 -56.9% Dec 31, 2019
Q3 2019 207 -337 -61.9% Sep 30, 2019
Q2 2019 233 -409 -63.8% Jun 30, 2019
Q1 2019 262 -438 -62.6% Mar 31, 2019
Q4 2018 417 -279 -40.1% Dec 31, 2018
Q3 2018 544 +30.4 +5.91% Sep 30, 2018
Q2 2018 642 +194 +43.2% Jun 30, 2018
Q1 2018 700 +299 +74.8% Mar 31, 2018
Q4 2017 696 +412 +145% Dec 31, 2017
Q3 2017 514 +177 +52.4% Sep 30, 2017
Q2 2017 448 +46.1 +11.5% Jun 30, 2017
Q1 2017 400 +17.6 +4.61% Mar 31, 2017
Q4 2016 284 -200 -41.4% Dec 31, 2016
Q3 2016 337 -288 -46.1% Sep 30, 2016
Q2 2016 402 -275 -40.6% Jun 30, 2016
Q1 2016 383 Mar 31, 2016
Q4 2015 484 Dec 31, 2015
Q3 2015 626 Sep 30, 2015
Q2 2015 677 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.